Congress: ASCO 2024

American Society of Clinical Oncology Annual Meeting 2024

Showing 1 abstract

Sort by:

#LBA5 ASCO 2024

Efficacy of Drug X in Metastatic Lung Cancer: A Phase 3 Study

Dr. John Smith, Dr. Sarah...

Phase 3 study demonstrates significant improvement in progression-free survival with Drug X in metastatic NSCLC patients.

Oncology Pfizer Clinical Trial